共查询到20条相似文献,搜索用时 31 毫秒
1.
2.
3.
N Hemati SE Ross RL Erickson GE Groblewski OA MacDougald 《Canadian Metallurgical Quarterly》1997,272(41):25913-25919
4.
5.
6.
7.
8.
9.
10.
11.
12.
13.
14.
P Zhang A Iwama MW Datta GJ Darlington DC Link DG Tenen 《Canadian Metallurgical Quarterly》1998,188(6):1173-1184
15.
16.
Finkel-Biskis-Reilly (FBR) osteosarcoma virus v-Fos causes tumors of mesenchymal origin, including osteosarcomas, rhabdomyosarcomas, chondrosarcomas, and liposarcomas. Because the cell of origin in all these tumors is a pluripotent mesenchymal cell, the variety of tumors seen in mice which express FBR v-Fos implies that FBR v-Fos inhibits multiple differentiation pathways. To study the mechanism of FBR v-Fos' inhibition of mesenchymal differentiation, we utilized an in vitro model of adipocyte differentiation. We show by both morphological and biochemical means that FBR v-Fos inhibits adipocyte differentiation in vitro. This inhibition is due to FBR v-Fos' inhibition of the growth arrest characteristic of terminal differentiation and FBR v-Fos' inhibition of the expression and activity of a key regulator of this growth arrest, C/EBPalpha. The in vitro inhibition of adipogenesis by FBR v-Fos has in vivo significance as immunostaining of FBR v-Fos-induced tumors shows no CCAAT/enhancer binding protein (EBP)-alpha expression. These data implicate C/EBPalpha as a protein involved in the generation of liposarcomas. 相似文献
17.
18.
19.